Oct 03, 2023 / 03:00PM GMT
Operator
Good day and welcome to Trinity Biotech announces second-quarter financial results. (Operator Instructions) Please note that this event is being recorded. I'd like to turn the call over to Mr. Joe Diaz of Lytham Partners. please go ahead.
Joe Diaz - Lytham Partners - IR
Thank you, operator, and thanks all of you for joining us today to review the financial results of Trinity Biotech for the second quarter of 2023. Joining us on today's call are Aris Kekedjian, Chief Executive Officer; and John Gillard, Chief Financial Officer. At the conclusion of today's prepared remarks, we will open the call for a question-and-answer session.
Before we begin, please note that statements made during this conference call may be deemed forward-looking statements within the meaning of Federal securities laws. These statements are subject to known and unknown risks and uncertainties that may cause actual events to differ from those expressed or implied in such statements. These risks include, but are not limited to, those set forth in the Risk Factor statement in the
Q2 2023 Trinity Biotech PLC Earnings Call Transcript
Oct 03, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers